Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.18468
Abstract: Receptor tyrosine kinase AXL (RTK-AXL) is regarded as a suitable target in glioblastoma (GBM) therapy. Since AXL kinase inhibitors are about to get approval for clinical use, patients with a potential benefit from therapy targeting… read more here.
Keywords: glioblastoma; axl; phospho axl; associated significant ... See more keywords